Fifty percent of patients with EOFAD have mutations either in presenilin 1 (PSEN1), presenilin 2 (PSEN 2), or amyloid precursor protein (APP) [26]. This evidence concerns the gene PSEN1 and early-onset autosomal dominant Alzheimer disease.